The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 27, 2009
Filed:
Dec. 21, 2005
Maria A. Glucksmann, Lexington, MA (US);
Mark J. Williamson, Saugus, MA (US);
Fong-ying Tsai, Newton, MA (US);
Laura A. Rudolph-owen, Medford, MA (US);
Rosanna Kapeller-libermann, Chestnut Hill, MA (US);
Rachel E. Meyers, Newton, MA (US);
Lillian Wei-ming Chiang, Edison, NJ (US);
John J. Hunter, Oakland, CA (US);
Maria A. Glucksmann, Lexington, MA (US);
Mark J. Williamson, Saugus, MA (US);
Fong-Ying Tsai, Newton, MA (US);
Laura A. Rudolph-Owen, Medford, MA (US);
Rosanna Kapeller-Libermann, Chestnut Hill, MA (US);
Rachel E. Meyers, Newton, MA (US);
Lillian Wei-Ming Chiang, Edison, NJ (US);
John J. Hunter, Oakland, CA (US);
Millennium Pharmaceuticals, Inc., Cambridge, MA (US);
Abstract
The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.